# FDA Inspection 1041182 - Biomat USA, Inc - January 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/cf8ea381-abc0-4036-841b-c38c335f0d66
Source feed: FDA_Inspections

> FDA Inspection 1041182 for Biomat USA, Inc on January 19, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041182
- Company Name: Biomat USA, Inc
- Inspection Date: 2018-01-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191252 - 2022-11-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b64f8e9e-d955-44c7-8ecc-3c270791a0d6)
- [FDA Inspection 847558 - 2013-08-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b43355dd-7491-4d6a-a90f-701e95853d33)
- [FDA Inspection 709479 - 2011-02-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/66585ce1-3902-4605-9d79-125560c75e91)

Company: https://www.keypedia.com/companies/biomat-usa-inc/ccd05292-a6fc-483e-ba88-8d7e91240ba4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d